James F Young's Net Worth

$10.1 Million

Estimate Recalculated Mar 26, 2024 06:05PM EST

Who is James F Young?

James F Young has an estimated net worth of $10.1 Million. This is based on reported shares across multiple companies, which include IOMAI CORP, NOVAVAX INC, and MEDIMMUNE INC /DE.

SEC CIK

James F Young's CIK is 0001219864

Past Insider Trading and Trends

2021 was James F Young's most active year for acquiring shares with 9 total transactions. James F Young's most active month to acquire stocks was the month of February. 2007 was James F Young's most active year for disposing of shares, totalling 11 transactions. James F Young's most active month to dispose stocks was the month of May. 2020 saw James F Young paying a total of $637,245.00 for 55,270 shares, this is the most they've acquired in one year. In 2007 James F Young cashed out on 1,965,320 shares for a total of $6,474,366.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IOMAI CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 16
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

NOVAVAX INC (NVAX) Snapshot price: $3.7975

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+7.19%
4.6K
—
—
68.59K
Jun 10 - Jun 12
Form 4
+2.24%
1.4K
—
—
63.99K
Jun 17
Form 4
—
0
—
—
0
Jun 10
Form 4
-16.65%
-12.50K
$73.58
-$919,764.60
62.59K
Mar 31
Form 4
—
0
$84.88
-$444,600.75
75.09K
Dec 31
Form 4
+15.36%
10K
—
—
75.09K
Jul 1
Form 4
+13.20%
7.59K
—
—
65.09K
Jun 25
Form 4
—
0
—
—
0
Jun 17
Form 4
+475.00%
47.5K
$121.81
-$1,396,793.28
57.5K
Mar 23 - Mar 25
Form 4
∞
10K
$82.18
-$1,244,014.50
10K
Dec 31 - Jan 1
Form 4
—
0
—
—
0
Dec 5
Form 4
—
0
—
—
0
Jun 25
Form 4
∞
1.5K
$48.83
$73,245.00
1.5K
Jun 3
Form 4/A
—
0
—
—
0
Dec 12
Form 4
—
0
—
—
0
Dec 12
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Dec 15
Form 4
-100.00%
-175.00K
$1.06
-$184,870.00
0
Aug 31
Form 4
—
0
—
—
0
Mar 16
Form 4
-36.36%
-100.00K
$1.39
-$138,980.00
175K
Mar 14
Form 4
—
0
—
—
0
Mar 15
Form 4
-11.76%
-50.00K
$9.47
-$473,615.00
375K
Jun 18
Form 4
—
0
—
—
0
Mar 5
Form 4
+6.25%
25K
$4.47
$111,837.50
425K
Mar 25
Form 4
—
0
—
—
0
Mar 6
Form 4
+33.33%
100K
$1.91
$191,000.00
400K
Jun 6
Form 4
+50.00%
100K
$2.03
$203,000.00
300K
Mar 11
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
—
—
0
Mar 1
Form 4
+83.33%
200K
$1.46
$292,000.00
440K
Dec 1
Form 4
—
0
—
—
0
Apr 19
Form 4
—
0
—
—
0
Mar 10
Form 4
—
0
—
—
0
Apr 5
Form 3
—
0
—
—
0
No matching records found

MEDIMMUNE INC /DE No price found

President, R&D

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 18
Form 4
-89.07%
-111.63K
$58.00
-$6,474,366.00
13.7K
Jun 4
Form 4
—
0
—
—
0
Feb 15
Form 4
—
0
—
—
0
Feb 23
Form 4
—
0
$17.68
-$258,103.58
17.28K
Feb 3
Form 4
∞
59.48K
$9.59
$299,959.38
54.21K
Sep 23
Form 4
—
0
—
—
0
Feb 16
Form 4
—
0
—
—
0
Mar 4
No matching records found